- Home
- CRBP vs XPOF Comparison
CRBP vs XPOF Comparison
Compare CRBP & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRBP | XPOF |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 205.6M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRBP | XPOF |
|---|---|---|
| Price | $4.12 | $4.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 8 |
| Target Price | ★ $34.89 | $5.60 |
| AVG Volume (30 Days) | ★ 860.0K | 660.7K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.24 |
| EPS | N/A | ★ N/A |
| Revenue | $4,822,272.00 | ★ $11,092,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $131.00 | $5.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 97.62 | N/A |
| 52 Week Low | $3.87 | $3.57 |
| 52 Week High | $12.88 | $9.25 |
Technical Indicators
Market Signals| Indicator | CRBP | XPOF |
|---|---|---|
| Relative Strength Index (RSI) | 24.53 | 49.63 |
| Support Level | N/A | $3.70 |
| Resistance Level | $8.13 | $5.21 |
| Average True Range (ATR) | 0.32 | 0.27 |
| MACD | 0.11 | -0.04 |
| Stochastic Oscillator | 18.76 | 59.54 |
Price Performance
Historical ComparisonAbout CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.